J. Theodore Phillips

Statistics

Publications

Citations

10.1K

H-Index

Active since

1978

Affiliations

Biogen (United States)(Current)

J. Theodore Phillips is an author at Biogen (United States) specializing in multiple sclerosis, multiple sclerosis therapy, and multiple sclerosis pharmacotherapy.

Publications per year

1978–2021

Publications

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Robert J. Fox, David H. Miller, J. Theodore Phillips et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text

Medicine, Neurology, Pharmacology +6

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

Eva Havrdová, Steven Galetta, Michael Hutchinson et al. · The Lancet Neurology · 2009 · 473 citations

Life Sciences, Neurology, Pharmacotherapy +10

Immune surveillance in multiple sclerosis patients treated with natalizumab

Olaf Stüve, Christina M. Marra, Keith R. Jerome et al. · Annals of Neurology · 2006 · 437 citations · Full text

Life Sciences, Immunology, Neurology +15

Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia Gravis

Richard S. A. Tindall, JULIA A. ROLLINS, J. Theodore Phillips et al. · New England Journal of Medicine · 1987 · 391 citations

Medicine, Pharmacology, Pharmacotherapy +13

1–5 of 59